NASDAQ: SABSSab Biotherapeutics Inc Stock Ownership - Who owns Sab Biotherapeutics?
Insider buying vs selling
Have Sab Biotherapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when SABS insiders and whales buy or sell their stock.
SABS Shareholders
What type of owners hold Sab Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christine E. Hamilton | 12.35% | 11,237,694 | $37.65M | Insider |
| Edward D. Hamilton | 11.02% | 10,023,848 | $33.58M | Insider |
| Andrew Moin | 7.45% | 6,783,028 | $22.72M | Insider |
| Ilan Katz | 6.70% | 6,097,150 | $20.43M | Insider |
| Eddie Joe Sullivan | 5.75% | 5,232,304 | $17.53M | Insider |
| Samuel J. Reich | 4.19% | 3,814,524 | $12.78M | Insider |
| Big Cypress Holdings LLC | 3.35% | 3,047,825 | $10.21M | Insider |
| Helen K. Ellias | 3.14% | 2,857,142 | $9.57M | Insider |
| Sessa Capital Master LP | 2.42% | 2,198,457 | $7.36M | Insider |
| Jeffrey G. Spragens | 0.43% | 394,989 | $1.32M | Insider |
SABS vs Biotech Stocks
Sab Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.